Biologics Hearing: What They’re Saying
2 CommentsBy Ed Silverman // March 8th, 2007 // 11:46 am
For anyone who forgot, the Senate Health, Education, Labor and Pensions Committee, which is chaired by Ted Kennedy, is holding a hearing today on generic biologics. There are competing proposals in play, and gobs of money at stake.
Here are a few statements issued this morning from folks who have skin in the game:
Johnson & Johnson’s Jay Siegel, who heads biotech research;
PCMA’s Mark Merritt, who heads the PBM trade group;
BIO’s Jim Greenwood.
[tags]BIO, Biologics, Generics, Johnson & Johnson, PBMs[/tags]
Melody
Ed–
Didn’t Mr. and/or Mrs. John Q. Public get an invitation?
ed
Yes, I believe they were, but I didn’t receive their handout. :)